News

Glysantis Inc. to Participate in Partnering Meetings During BIO International Convention June 4-7 in Boston

Guelph, May 28, 2018 – Glysantis Inc., a privately held biotechnology company developing novel nanomedicines, announced today that it will be participating in business partnering meetings during the 2018 BIO International Convention, to be held in Boston on June 4-7, 2018. Glysantis Inc. is one of 23 Ontario biotechnology companies selected to join the Ontario… Read more Glysantis Inc. to Participate in Partnering Meetings During BIO International Convention June 4-7 in Boston

Glysantis Inc. Selected as a Finalist in RESI Toronto Innovation Challenge at Toronto Health Innovation Week 2018.

Guelph, April 4, 2018 – Glysantis Inc. today announced that it has been selected as a finalist in the RESI at MaRS Toronto Innovation Challenge. Glysantis Inc. will be one of 30 early-stage biotech, med-tech and digital health startups to showcase a poster vying for “RESI bucks” given to attendees to “invest” in the most… Read more Glysantis Inc. Selected as a Finalist in RESI Toronto Innovation Challenge at Toronto Health Innovation Week 2018.

Glysantis™ Inc. to Present at the Biotech Showcase™ Annual Conference on January 10, 2018

Guelph, Jan 3, 2018 – Glysantis™ Inc. today announced that it will present at Biotech Showcase™ 2018, to be held January 8–10 during the most important week in healthcare at the Hilton San Francisco Union Square. Ricky Ghoshal, Sr. Business Development Associate, will present at the Biotech Showcase™ as follows: Date: Wednesday, January 10, 2018… Read more Glysantis™ Inc. to Present at the Biotech Showcase™ Annual Conference on January 10, 2018